Hydroxylation of lauramide diethanolamine by liver microsomes

Drug Metabolism and Disposition

Volumn 24, Issue 2, 1996, Pages 180-186

  Merdink, James ^a   Decosta, Kristi ^b   Mathews, James M ^b   Jones, Carleton B ^a   Okita, Janice Rice ^a   Okita, Richard T ^a,c  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; LAURIC ACID; N,N BIS(2 HYDROXYETHYL)LAURAMIDE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG HYDROLYSIS; GAS CHROMATOGRAPHY; KIDNEY MICROSOME; LIVER MICROSOME METABOLISM; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKANE 1-MONOOXYGENASE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; EMOLLIENTS; ENZYME INDUCTION; ETHANOLAMINES; HUMANS; HYDROXYLATION; KIDNEY; LAURIC ACIDS; MALE; MICROSOMES; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030060827     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. W. A. Poucher: "Poucher's Perfumes, Cosmetics and Soaps. The Raw Materials of Perfumery" (A. J. Jouhar, ed.), vol. 1, 9th ed. Chapman & Hall, New York, 1991.
2. Department of Health and Human Services: "National Toxicology Program Annual Plan for Fiscal Year 1994." Department of Health and Human Services, Washington, D.C., 1994.
3. J. Mathews, K. deCosta, J. Merdink, and R. T. Okita Metabolism and disposition of lauramide diethanolamine in rat and human. 10th International Symposium on Microsomes and Drug Oxidations, 598, 1994.
4. R. T. Okita: Effect of peroxisome proliferators on microsomal P450 reactions. In "Peroxisome Proliferators: Unique Inducers of Drug-Metabolizing Enzymes" (D. E. Moody, ed.), pp. 37-49. CRC Press, Boca Raton, FL, 1994.
5. R. T. Okita and J. R. Okita: Characterization of a cytochrome P450 from di(2-ethylhexyl)phthalate-treated rats which hydroxylates fatty acids. Arch. Biochem. Biophys. 294, 475-481 (1992).
6. M. D. Boleda, N. Saubi, J. Farrés, and X. Pares: Physiological substrates for rat alcohol dehydrogenase classes: aldehydes of lipid peroxidation, ω-hydroxy fatty acids, and retinoids. Arch. Biochem. Biophys. 307, 85-90 (1993).
7. E. Christensen, M. Grønn, T.-A. Hagve, and B O. Christophersen: Omega-oxidation of fatty acids studied in isolated liver cells. Biochim. Biophys. Acta 1081, 167-173 (1991).
8. P. B. Mortensen: Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Biochim. Biophys. Acta 1124, 71-79 (1992).
9. Å. Ellin and S. Orrenius: Fatty acid hydroxylation in rat kidney cortex microsomes. Mol. Cell. Biochem. 8, 69-79 (1975).
10. K of rat kidney cortex microsomes: further studies on its interaction with fatty acids. Arch. Biochem. Biophys. 158, 597-604 (1973).
11. J. R. Okita, P. J. Castle, and R. T. Okita: Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J. Biochem. Toxicol. 8, 135-144 (1993).
12. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
13. R. T. Okita, J. E. Clark, J. R. Okita, and B. S. S. Masters: ω- and (ω-1)-hydroxylation of eicosanoids and fatty acids by high performance liquid chromatography. In "Methods of Enzymology" (M. R. Waterman and E. J. Johnson, eds.), vol. 206, pp. 432-441. Academic Press, San Diego, 1990.
14. C. S. Chaurasia, M. A. Alterman, P. Lu, and R. P. Hanzlik: Biochemical characterization of lauric acid ω-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein. Arch. Biochem. Biophys. 317, 161-169 (1995).
15. A. Y. H. Lu, K. W. Junk, and M. J. Coon: Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three compounds. J Biol. Chem. 244, 3714-3721 (1969).
16. F. Wada, A. Shibata, M. Goto, and Y. Sakamoto: Participation of the microsomal electron transport system involving P-450 in ω-oxidation of fatty acids. Biochim. Biophys. Acta 162, 518-524 (1969).
17. P. Straub, M. Lloyd, E. F. Johnson, and B. Kemper: Differential effects of mutations in substrate recognition site 1 of cytochrome P450 2C2 on lauric acid and progesterone hydroxylation. Biochemistry 33, 8029-8034 (1994).
18. Y. Amet, F. Benhou, T. Goasduff, J. P. Salaun, L. Le Breton, and J. F. Menez: Evidence that cytochrome P450 2E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Comm. 203, 1168-1174 (1994).
19. T. Fukuda, Y. Imai, M. Komori, M. Nakamura, E. Kusunose, K. Satouchi, and M. Kusunose: Replacement of Thr-303 of P450 2E1 with serine modifies the regioselectivity of its fatty acid hydroxylase activity. J. Biochem. 113, 7-12 (1993).
20. T. Fukuda, Y. Imai, M. Komori, M. Nakamura, E. Kusunose, K. Satouchi, and M. Kusunose: Different mechanisms of regioselection of fatty acid hydroxylation by laurate (ω-1)-hydroxylating P450s. P450 2C2 and P450 2E1. J. Biochem. 115, 338-344 (1994).
21. P. J. Castle, J. L. Merdink, J. R. Okita, S. A. Wrighton, and R. T. Okita: Human liver lauric acid hydroxylases. Drug Metab. Dispos. 23, 1037-1043 (1995).
22. A. Nilsson, H. Arey, J. I. Pedersen and E. N. Christiansen: The effect of high-fat diets on microsomal lauric acid hydroxylation in rat liver. Biochim. Biophys. Acta 879, 209-214 (1986).
23. S. Jakobsson, H. Thor, and S. Orrenius: Fatty acid inducible cytochrome P-454 of rat kidney cortex microsomes. Biochem. Biophys. Res. Comm. 39, 1073-1080 (1970).
24. P. Tollet, M. Strömstedt, L. Frøyland R. K. Berge, and J.-Å. Gustafsson: Pretranslational regulation of cytochrome P4504A1 by free fatty acidsin primary cultures of rat hepatocytes. J. Lipid Res. 35, 248-254 (1994).
25. P. Bentley, I. Calder, C. Elcombe, P. Grasso, D. Stringer, and H.-J. Wiegand: Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 11, 857-907 (1993).
26. J. K. Reddy, D. L. Azarnoff, and C. R. Sitori: Hepatic peroxisome proliferation: induction by BR 931, a hypolipidemic analog of WY 14,643. Arch. Int. Pharmacodyn. 234, 4-14 (1978).
27. L. L. Hsieh, H. Shinozuka, and I. B. Weinstein: Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator. Br. J. Cancer 64, 815-820 (1991).